Improving risk‐stratification of natalizumab‐associated PML-Reference-Cited by-同舟云学术

Improving risk‐stratification of natalizumab‐associated PML

Published:2021-02-04 Issue:3 Volume:8 Page:696-703
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann. Clin. Transl. Neurol.

Author:

Tugemann Bastian¹^ORCID,Berger Joseph R.²

Affiliation:

1. Munich Germany

2. Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51130

Reference43 articles.

1. Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy

2. Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

3. New algorithm to estimate risk of natalizumab‐associated progressive multifocal leukoencephalopathy (PML) in anti‐JCV antibody positive patients: analyses of clinical trial data to provide further temporal precision and inform clinical practice;Koendgen H;Mult Scler,2016

4. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

5. Risk of natalizumab‐associated PML in patients with MS is reduced with extended interval dosing;Zhovtis Ryerson L;Neurology,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy;Frontiers in Immunology;2024-07-17

2. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification;Journal of the Neurological Sciences;2024-06

3. Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab;Journal of Clinical Medicine;2023-12-19

4. Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study;Journal of Neurology;2023-09-20

5. Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literature;Neurological Sciences;2023-03-17